Further characterization of the c-mos transcript and its cell cycle specific expression in NIH3T3 cells

Area of Science:

• Molecular Biology
• Cell Cycle Regulation
• Oncogene Research

Background:

• The c-mos proto-oncogene is mainly expressed in germ cells.
• Previous research indicated c-mos RNA expression in mouse somatic cells, peaking in G2 phase.
• The precise regulation of somatic c-mos expression remained unclear.

Purpose of the Study:

• To identify the transcription start site (TSS) of the G2-specific c-mos transcript in mouse somatic cells.
• To investigate the regulatory role of upstream sequences in controlling c-mos expression during the cell cycle.
• To understand the potential accumulation of c-Mos protein in M phase.

Main Methods:

• Reverse Transcription Polymerase Chain Reaction (RT-PCR) to detect and analyze c-mos RNA.
• RNase protection assays to precisely map RNA transcripts and identify the TSS.
• Reporter gene assays (luciferase) to assess the activity of upstream regulatory sequences.

Main Results:

• The TSS for the G2-specific c-mos transcript was mapped approximately 1580 bp upstream of the open reading frame.
• Upstream sequences containing the identified TSS demonstrated the highest reporter gene expression during M phase.
• These findings indicate cell cycle-dependent transcriptional regulation of c-mos.

Conclusions:

• Somatic c-mos transcripts are produced during the G2 phase of the cell cycle.
• The identified upstream regulatory elements drive expression in M phase.
• Low levels of c-Mos protein are likely to accumulate during M phase, despite transcriptional peaking in G2.